For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250501:nRSA1165Ha&default-theme=true
RNS Number : 1165H GSK PLC 01 May 2025
GSK plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure Guidance and
Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market
of the following:
The Company's issued share capital as at 30 April 2025 consisted of
4,315,241,378 shares of 31 ¼ pence each ('Ordinary Shares'), of which
204,800,108 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is 4,110,441,270.
This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the Financial
Conduct Authority's Disclosure Guidance and Transparency Rules.
Notifications may be sent to company.secretary@gsk.com
(mailto:company.secretary@gsk.com) .
V A Whyte
Company Secretary
1 May 2025
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRBXGDUCSGDGUB